RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma

RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma

N6-methyladenosine (m6A) is the most common modification in eukaryotic RNAs and plays a vital role in the tumorigenesis and metastasis of various cancers. However, a comprehensive study of m6A methylation regulators in lung adenocarcinoma (LUAD) is still lacking. The present study aimed to systemati...

Full description

Bibliographic Details
Main Authors:	JinFeng Liu, Zhi Li, Iokfai Cheang, Jinghang Li, Chunlei Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Genetics
Subjects:	lung adenocarcinoma TCGA m6A modification regulators prognosis immunotherapy response
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.777399/full

Similar Items

A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma
by: Dongjun Dai, et al.
Published: (2022-12-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma
by: Yang Li, et al.
Published: (2021-02-01)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
by: Ye Wang, et al.
Published: (2022-11-01)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
by: Jianlong Tan, et al.
Published: (2022-09-01)

Exploration of Identification and Prognostic Analysis of a Novel Immune-Related lncRNA Pair Signature and Immune Landscape in Esophageal Adenocarcinoma: A New Method Based on “Continuous Learning” Model
by: Yang Yu, et al.
Published: (2023-06-01)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
by: Xing Fu, et al.
Published: (2022-09-01)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
by: Xiaoshun Shi, et al.
Published: (2020-02-01)

m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
by: Hansheng Wu, et al.
Published: (2022-09-01)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
by: Liexi Xu, et al.
Published: (2022-08-01)

Development and Validation of a Prognosis-Prediction Signature for Patients with Lung Adenocarcinoma Based on 11 Telomere-Related Genes
by: Jia Liu, et al.
Published: (2023-10-01)

Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis
by: Fang‐lu Qin, et al.
Published: (2020-09-01)

A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma
by: Tian Lan, et al.
Published: (2019-07-01)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
by: Gujie Wu, et al.
Published: (2023-03-01)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
by: Xincheng Zhou, et al.
Published: (2022-11-01)

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis
by: Jihang Luo, et al.
Published: (2020-11-01)

Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation
by: Muyu Kuang, et al.
Published: (2023-03-01)

Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics
by: Xiang Y, et al.
Published: (2024-02-01)

Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
by: Lulu He, et al.
Published: (2020-12-01)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
by: Hao Lu, et al.
Published: (2022-09-01)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
by: Wuguang Chang, et al.
Published: (2023-03-01)

Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma
by: Yuan Nie, et al.
Published: (2021-02-01)

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
by: Yang Zhai, et al.
Published: (2021-03-01)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
by: Qinglin Li, et al.
Published: (2023-02-01)

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma
by: Li-Ying OuYang, et al.
Published: (2022-08-01)

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies
by: Yin Li, et al.
Published: (2019-09-01)

Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods
by: Ruiying Sun, et al.
Published: (2020-02-01)

Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma
by: Jian Ji, et al.
Published: (2023-08-01)

Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
by: Jinsong Wang, et al.
Published: (2023-02-01)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
by: Qianhe Ren, et al.
Published: (2023-05-01)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
by: Kaibin Zhu, et al.
Published: (2022-06-01)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
by: Taohua Yue, et al.
Published: (2021-08-01)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
by: Weibiao Zeng, et al.
Published: (2023-07-01)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
by: Zhengliang Tu, et al.
Published: (2021-04-01)

Comprehensive analysis of the prognostic value and immune implications of the TTK gene in lung adenocarcinoma: a meta-analysis and bioinformatics analysis
by: Bo Li, et al.
Published: (2022-05-01)

CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro
by: Qiwei Yao, et al.
Published: (2022-01-01)

Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
by: Guo-Liang Zheng, et al.
Published: (2022-04-01)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
by: Zhouhua Li, et al.
Published: (2022-08-01)

Prognostic roles of a novel basement membranes-related gene signature in lung adenocarcinoma
by: Xingzhuang Zhu, et al.
Published: (2023-02-01)

Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy
by: Xiaodong Yang, et al.
Published: (2021-06-01)